2-(4-bromo-3-methylphenoxy)ethanol | 26738-92-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-(4-bromo-3-methylphenoxy)ethanol
• 英文别名: 2-(4-Bromo-3-methylphenoxy)ethan-1-ol
• CAS: 26738-92-1
• 化学式: C₉H₁₁BrO₂
• 分子量: 231.089
• InChiKey: NLCZTXDWYTUVHI-UHFFFAOYSA-N

物化性质

• 沸点：
  323.4±27.0 °C(Predicted)
• 密度：
  1.445±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(4-bromo-3-methylphenoxy)ethanol 在 N-溴代丁二酰亚胺(NBS) 、 三苯基膦 作用下， 以 二氯甲烷 为溶剂， 以89%的产率得到1-bromo-4-(2-bromoethoxy)-2-methylbenzene
  参考文献：
  名称：

  Synthesis of End-Group Functionalized P3HT: General Protocol for P3HT/Nanoparticle Hybrids

  摘要：

  Poly(3-hexylthiophene)s were synthesized with phosphonic ester, pyridine, thiol, and phenol end-groups using functionalized air-stable Ni initiators. The protected thiol- and phenol-functionalized P3HTs were converted into thiol and phenol P3HTs by quantitative postpolymerization reactions. H-1 NMR and MALDI-ToF analysis showed very high degrees of functionalization and strong control over the polymerization except for the pyridine functionalized P3HT. These functional end-groups were used to prepare hybrid materials from a broad variety of nanoparticles, including metal oxides, quantum dots, and noble metals.

  DOI：

  10.1021/ma401809e
• 作为产物：
  描述：

  碳酸乙烯酯 、 4-溴-3-甲基苯酚 在 potassium carbonate 作用下， 以 甲苯 为溶剂， 反应 24.0h， 以98%的产率得到2-(4-bromo-3-methylphenoxy)ethanol
  参考文献：
  名称：

  “Clickable” elastins: elastin-like polypeptides functionalized with azide or alkyne groups

  摘要：

  通过铜催化叠氮烷基环加成法，生物合成了具有叠氮或烷基官能团的弹性蛋白样多肽（ELPs），并将其与多种（生物）分子偶联。

  DOI：

  10.1039/b903903a

文献信息

• AMINO ALCOHOL DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USE OF THESE
  申请人：Kissei Pharmaceutical Co., Ltd.

  公开号：EP1679304A1

  公开（公告）日：2006-07-12

  The present invention provides compounds represented by general formula (I): a prodrug thereof, or pharmaceutical acceptable salts thereof, wherein R1 is hydrogen or lower alkyl; each of R2 and R3 is independently hydrogen or lower alkyl; each of R4, R5 and R6 is independently hydrogen, halogen, lower alkyl or lower alkoxy; R7 is hydrogen or lower alkyl; R8 is hydrogen, halogen, lower alkyl, lower alkoxy, etc; R9 is -COR10, -A1-COR10, -O-A2-COR10, etc; Ar is optionally substituted phenyl or heteroaryl; and A is a bond, -OCH2-, etc, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.

  本发明提供了由通式（I）表示的化合物： 其前药，或其药用可接受的盐，其中R1是氢或较低的烷基；R2和R3中的每一个独立地是氢或较低的烷基；R4、R5和R6中的每一个独立地是氢、卤素、较低的烷基或较低的烷氧基；R7是氢或较低的烷基；R8是氢、卤素、较低的烷基、较低的烷氧基等；R9是-COR10、-A1-COR10、-O-A2-COR10等；Ar是可选择地取代的苯基或杂环芳基；A是键，-OCH2-等，具有强效和选择性的β3-肾上腺素受体刺激活性。本发明还提供了含有所述化合物的药物组合物，以及其用途。
• “Clickable” elastins: elastin-like polypeptides functionalized with azide or alkyne groups
  作者：Rosalie L. M. Teeuwen、Sander S. van Berkel、Tim H. H. van Dulmen、Sanne Schoffelen、Silvie A. Meeuwissen、Han Zuilhof、Frits A. de Wolf、Jan C. M. van Hest

  DOI：10.1039/b903903a

  日期：——

  Elastin-like polypeptides (ELPs) functionalized with azide or alkyne groups were produced biosynthetically and coupled via the Cu-catalyzed azide–alkyne cycloaddition to a variety of (bio)molecules.

  通过铜催化叠氮烷基环加成法，生物合成了具有叠氮或烷基官能团的弹性蛋白样多肽（ELPs），并将其与多种（生物）分子偶联。
• Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
  申请人：Kobayashi Junichi

  公开号：US20060128807A1

  公开（公告）日：2006-06-15

  The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R 1 and R 2 are each hydrogen or lower alkyl; R 3 , R 4 , R 5 and R 6 are each hydrogen, halogen, lower alkyl or lower alkoxy; R 7 and R 8 are each hydrogen, halogen, lower alkyl, halo-lower alkyl, lower alkoxy, cycloalkyl, aryl, heteroaryl, cyano, a hydroxyl group, lower acyl, carboxy or the like; R 9 is —C(O)—R 10 , -A 1 -C(O)—R 10 , —O-A 2 -C(O)—R 10 or a tetrazol-5-yl group, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.

  本发明提供一般式（I）所表示的化合物或其药学上可接受的盐，其中R1和R2均为氢或较低的烷基；R3、R4、R5和R6均为氢、卤素、较低的烷基或较低的烷氧基；R7和R8均为氢、卤素、较低的烷基、卤代较低的烷基、较低的烷氧基、环烷基、芳基、杂芳基、氰基、羟基、较低的酰基、羧基或类似物；R9为—C（O）—R10、-A1-C（O）—R10、—O-A2-C（O）—R10或四唑-5-基团，其表现出强效和选择性的β3肾上腺素能受体刺激活性。本发明还提供含有该化合物的药物组合物及其用途。
• Amino alcohol derivatives, medicinal composition containing the same, and use of these
  申请人：Kobayashi Junichi

  公开号：US20070078184A1

  公开（公告）日：2007-04-05

  The present invention provides compounds represented by general formula (I): a prodrug thereof, or pharmaceutical acceptable salts thereof, wherein R 1 is hydrogen or lower alkyl; each of R2 and R3 is independently hydrogen or lower alkyl; each of R 4 , R 5 and R 6 is independently hydrogen, halogen, lower alkyl or lower alkoxy; R 7 is hydrogen or lower alkyl; R 8 is hydrogen, halogen, lower alkyl, lower alkoxy, etc; R 9 is —COR 10 , -A 1 -COR 10 , —O-A 2 -COR 10 , etc; Ar is optionally substituted phenyl or heteroaryl; and A is a bond, —OCH 2 —, etc, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.

  本发明提供了由通式（I）表示的化合物：其前体，或其药学上可接受的盐，其中R1是氢或较低的烷基；R2和R3各自独立地是氢或较低的烷基；R4，R5和R6各自独立地是氢，卤素，较低的烷基或较低的烷氧基；R7是氢或较低的烷基；R8是氢，卤素，较低的烷基，较低的烷氧基等；R9是-COR10，-A1-COR10，-O-A2-COR10等；Ar是可选取代的苯基或杂环芳基；A是键，-OCH2-等，这些化合物表现出潜在和选择性的β3-肾上腺素能受体刺激活性。本发明还提供了含有上述化合物的药物组合物及其用途。
• AMINO ALCOHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND USE THEREOF
  申请人：Kissei Pharmaceutical Co., Ltd.

  公开号：EP1593666B1

  公开（公告）日：2008-07-02